Population
5 patients (three men and two women; age 39-65 years) with Acral myxoinflammatory fibroblastic sarcoma (AMIFS)
Design
Case_series
Follow-up
2 weeks to 95 months (mean 54 months)
Authors
Loading...
AMIFS may metastasize with fatal outcomes; challenges exclusive low-grade classification but remains hypothesis-generating from case reports.
AMIFS are rare tumors that can present as slow-growing masses and may develop metastases, challenging the notion that they are exclusively low-grade neoplasms.
Hassanein et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: